Introduction: Multivisceral transplantations were initially done in animal models to understand the immunological effects and then in human beings as salvage procedure for unresectable complex abdominal malignancies. With advancement in surgical techniques, availability of better immunosuppressive drugs and development of better postoperative management protocols, outcomes have been improved after these complex surgical procedures. The aim of this study is to analyze and report results of multivisceral, modified multivisceral and small bowel transplantations done at our center.

Materials and Methods: In this study medical records of all patients of multivisceral, modified multivisceral and small bowel transplants were retrospectively analyzed.

Results: Most common indications in our series were unresectable carcinoma of pancreas followed by short bowel syndrome. Ten patients are alive with a median follow up of 8.7±7.5 months (range, 3-32 months). Eight patients (out of 18 cases) in our series died in post operative course. The most common cause of post transplantation death was septicemia.

Conclusions: Multivisceral and small bowel transplants are promising treatments for complex abdominal pathologies.